新型免疫抑制剂在特发性膜性肾病治疗中的研究进展

Research progress on new immunosuppressive agents in treatment of idiopathic membranous nephropathy

特发性膜性肾病是成人肾病综合征最常见的原因。传统的免疫抑制剂虽能提高缓解率,但存在严重不良反应,部分患者在数年内可进展为终末期肾病。本文主要介绍新型免疫抑制剂在特发性膜性肾病治疗中的进展。

Idiopathic membranous nephropathy is the most common cause of nephrotic syndrome in adults.Although conventional immunosuppressive drugs can improve the remission rate,there are serious adverse effects and some patients can progress to end-stage renal disease within a few years.This article mainly introduces the progress on new immunosuppressive agents in the treatment of idiopathic membranous nephropathy.